CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Zero Based Budgeting Guidelines explain how to allocate every dollar to a category, ensuring you cover needs, wants, and savings with discipline.
16,010 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Sen. Bernie Sanders rolls out a blueprint for public ownership of AI firms and a $1,000 annual payout to Americans, a...
A new five-pillar framework unveiled by a top U.S. official signals a hard turn toward reshoring, tougher trade terms...
Five-year horizons test even strong crypto theses. This article breaks down XRP's potential paths and practical steps...
A Suzhou court ruled that a local tea chain infringed Louis Vuitton’s trademark, ordering a $1.5 million payment and ...
A high-profile insider sale can spark questions about a company’s future. This article breaks down the HeartFlow CEO'...
A FormFactor director recently sold 3,000 shares in a move that drew attention from investors. This article breaks do...
One mega-cap could re-enter the elite $4 trillion club, powered by AI, cloud momentum, and strong cash flow. This pie...
A notable stake from an experienced manager in a healthcare diagnostics stock signals a thoughtful, long term thesis....
If you want amplified daily moves, SPXL and TQQQ offer two very different paths. This guide breaks down costs, risk, ...
Circle helped popularize stablecoins with USDC, but looming regulatory moves could reshape its growth path. This arti...
A federal court clears a $71 million ETH transfer on Arbitrum to Aave, but North Korea-linked creditors retain legal ...